Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Liver Diseases

  Free Subscription


30.10.2017

1 Anticancer Res
3 Biochem Biophys Res Commun
1 BMC Gastroenterol
2 Dig Dis Sci
2 Eur Radiol
2 Gastrointest Endosc
1 Gut
8 Hepatology
1 J Gastroenterol Hepatol
4 J Hepatol
2 Oncogene
8 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Anticancer Res

  1. BAI YC, Hsia YC, Lin YT, Chen KH, et al
    Effect of Tumor Microenvironment on Selective Uptake of Boric Acid in HepG2 Human Hepatoma Cells.
    Anticancer Res. 2017;37:6347-6353.
    PubMed     Text format     Abstract available


    Biochem Biophys Res Commun

  2. CHEN YH, Chiu CC, Hung SW, Liu JY, et al
    Effects of plant- and animal-based high-fat diets on lipid storage and distribution in environmental bacteria-colonized gnotobiotic mice.
    Biochem Biophys Res Commun. 2017;493:1075-1081.
    PubMed     Text format     Abstract available

  3. WANG Y, Zhu K, Yu W, Wang H, et al
    MiR-181b regulates steatosis in nonalcoholic fatty liver disease via targeting SIRT1.
    Biochem Biophys Res Commun. 2017;493:227-232.
    PubMed     Text format     Abstract available

  4. IKAGA R, Li D, Yamazaki T
    Dietary beta-conglycinin prevents acute ethanol-induced fatty liver in mice.
    Biochem Biophys Res Commun. 2017;493:542-547.
    PubMed     Text format     Abstract available


    BMC Gastroenterol

  5. RATCHATASETTAKUL K, Rattanasiri S, Promson K, Sringam P, et al
    The inverse effect of meal intake on controlled attenuation parameter and liver stiffness as assessed by transient elastography.
    BMC Gastroenterol. 2017;17:50.
    PubMed     Text format     Abstract available


    Dig Dis Sci

  6. REDMAN JS, Natarajan Y, Hou JK, Wang J, et al
    Accurate Identification of Fatty Liver Disease in Data Warehouse Utilizing Natural Language Processing.
    Dig Dis Sci. 2017;62:2713-2718.
    PubMed     Text format     Abstract available

  7. KHOURY T, Asombang AW, Berzin TM, Cohen J, et al
    The Clinical Implications of Fatty Pancreas: A Concise Review.
    Dig Dis Sci. 2017;62:2658-2667.
    PubMed     Text format     Abstract available


    Eur Radiol

  8. PARK CJ, An C, Park S, Choi JY, et al
    Management of subcentimetre arterially enhancing and hepatobiliary hypointense lesions on gadoxetic acid-enhanced MRI in patients at risk for HCC.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5088.
    PubMed     Text format     Abstract available

  9. NAGAYAMA Y, Nakaura T, Oda S, Utsunomiya D, et al
    Dual-layer DECT for multiphasic hepatic CT with 50 percent iodine load: a matched-pair comparison with a 120 kVp protocol.
    Eur Radiol. 2017 Oct 23. doi: 10.1007/s00330-017-5114.
    PubMed     Text format     Abstract available


    Gastrointest Endosc

  10. HUANG JY, Samarasena JB, Tsujino T, Lee J, et al
    EUS-guided portal pressure gradient measurement with a simple novel device: a human pilot study.
    Gastrointest Endosc. 2017;85:996-1001.
    PubMed     Text format     Abstract available

  11. CHO DH, Lee SS, Oh D, Song TJ, et al
    Long-term outcomes of a newly developed hybrid metal stent for EUS-guided biliary drainage (with videos).
    Gastrointest Endosc. 2016 Sep 17. pii: S0016-5107(16)30579.
    PubMed     Text format     Abstract available


    Gut

  12. KIM GA, Lim YS, Han S, Choi J, et al
    High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B.
    Gut. 2017 Oct 21. pii: gutjnl-2017-314904. doi: 10.1136/gutjnl-2017-314904.
    PubMed     Text format     Abstract available


    Hepatology

  13. SHERMAN M
    Regorafenib for treatment of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29598.
    PubMed     Text format    

  14. PHILIPS CA, Kumar L, Augustine P
    Partial Splenic Artery Embolization for Severe Hepatic Myelopathy in Cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29597.
    PubMed     Text format     Abstract available

  15. JANSEN C, Moller P, Meyer C, Kolbe CC, et al
    Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29612.
    PubMed     Text format     Abstract available

  16. KO E, Seo HW, Jung G
    Telomere length and ROS levels are positively associated with a high risk of mortality and recurrence in hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29604.
    PubMed     Text format     Abstract available

  17. SHEN F, Li Y, Yang Wang, Sozzi V, et al
    Hepatitis B Virus Sensitivity to Interferon-alpha in Hepatocytes is More Associated with Cellular Interferon Response than with Viral Genotype.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29609.
    PubMed     Text format     Abstract available

  18. PRAKTIKNJO M, Book M, Luetkens J, Pohlmann A, et al
    Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29602.
    PubMed     Text format     Abstract available

  19. SHEN Q, Eun JW, Lee K, Kim HS, et al
    BANF1, PLOD3, SF3B4 as Early-stage Cancer Decision Markers and Drivers of Hepatocellular Carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29606.
    PubMed     Text format     Abstract available

  20. PATEL N, Sheehan-Dare G, Weir J, Verma S, et al
    Cutaneous metastasis as the first presentation of hepatocellular carcinoma.
    Hepatology. 2017 Oct 23. doi: 10.1002/hep.29615.
    PubMed     Text format    


    J Gastroenterol Hepatol

  21. ARAI J, Goto K, Stephanou A, Tanoue Y, et al
    Predominance of regorafenib over sorafenib: restoration of membrane-bound MICA in hepatocellular carcinoma cells.
    J Gastroenterol Hepatol. 2017 Oct 21. doi: 10.1111/jgh.14029.
    PubMed     Text format     Abstract available


    J Hepatol

  22. HUANG K, Du M, Tan X, Yang L, et al
    PARP1-mediated PPARalpha poly(ADP-ribosyl)ation suppresses fatty acid oxidation in non-alcoholic fatty liver disease.
    J Hepatol. 2017;66:962-977.
    PubMed     Text format     Abstract available

  23. KARLAS T, Petroff D, Sasso M, Fan JG, et al
    Individual patient data meta-analysis of controlled attenuation parameter (CAP) technology for assessing steatosis.
    J Hepatol. 2017;66:1022-1030.
    PubMed     Text format     Abstract available

  24. SANDBOTHE M, Buurman R, Reich N, Greiwe L, et al
    The microRNA-449 family inhibits TGF-beta-mediated liver cancer cell migration by targeting SOX4.
    J Hepatol. 2017;66:1012-1021.
    PubMed     Text format     Abstract available

  25. MOSCA A, Nobili V, De Vito R, Crudele A, et al
    Serum uric acid concentrations and fructose consumption are independently associated with NASH in children and adolescents.
    J Hepatol. 2017;66:1031-1036.
    PubMed     Text format     Abstract available


    Oncogene

  26. NAKAYAMA M, Sakai E, Echizen K, Yamada Y, et al
    Intestinal cancer progression by mutant p53 through the acquisition of invasiveness associated with complex glandular formation.
    Oncogene. 2017;36:5885-5896.
    PubMed     Text format     Abstract available

  27. REN T, Zhang H, Wang J, Zhu J, et al
    MCU-dependent mitochondrial Ca2+ inhibits NAD+/SIRT3/SOD2 pathway to promote ROS production and metastasis of HCC cells.
    Oncogene. 2017;36:5897-5909.
    PubMed     Text format     Abstract available


    PLoS One

  28. GARCIA-GARCIA R, Cruz-Gomez AJ, Mangas-Losada A, Urios A, et al
    Reduced resting state connectivity and gray matter volume correlate with cognitive impairment in minimal hepatic encephalopathy.
    PLoS One. 2017;12:e0186463.
    PubMed     Text format     Abstract available

  29. BHAT M, Tazari M, Sebastiani G
    Performance of transient elastography and serum fibrosis biomarkers for non-invasive evaluation of recurrent fibrosis after liver transplantation: A meta-analysis.
    PLoS One. 2017;12:e0185192.
    PubMed     Text format     Abstract available

  30. DONG J, Zhai B, Sun W, Hu F, et al
    Activation of phosphatidylinositol 3-kinase/AKT/snail signaling pathway contributes to epithelial-mesenchymal transition-induced multi-drug resistance to sorafenib in hepatocellular carcinoma cells.
    PLoS One. 2017;12:e0185088.
    PubMed     Text format     Abstract available

  31. TUDORANCEA I, Porumb V, Trandabat A, Neaga D, et al
    New experimental model for single liver lobe hyperthermia in small animals using non-directional microwaves.
    PLoS One. 2017;12:e0184810.
    PubMed     Text format     Abstract available

  32. LUNDGREN H, Martinsson K, Cederbrant K, Jirholt J, et al
    HLA-DR7 and HLA-DQ2: Transgenic mouse strains tested as a model system for ximelagatran hepatotoxicity.
    PLoS One. 2017;12:e0184744.
    PubMed     Text format     Abstract available

  33. WEISS TS, Lupke M, Ibrahim S, Buechler C, et al
    Attenuated lipotoxicity and apoptosis is linked to exogenous and endogenous augmenter of liver regeneration by different pathways.
    PLoS One. 2017;12:e0184282.
    PubMed     Text format     Abstract available

  34. KIM AY, Frantz S, Krishnan P, DeMulder D, et al
    Short-term imaging response after drug-eluting embolic trans-arterial chemoembolization delivered with the Surefire Infusion System(R) for the treatment of hepatocellular carcinoma.
    PLoS One. 2017;12:e0183861.
    PubMed     Text format     Abstract available

  35. RATNASARI N, Nurdjanah S, Sadewa AH, Hakimi M, et al
    Difference of polymorphism VEGF-gene rs699947 in Indonesian chronic liver disease population.
    PLoS One. 2017;12:e0183503.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: